-
Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call
18 Jun 2025 20:24 GMT
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today …
-
Jabil Inc. (NYSE:JBL) Q3 2025 Earnings Call Transcript
18 Jun 2025 12:38 GMT
… , 2025
Jabil Inc. beats earnings expectations. Reported EPS is … to Jabil Inc.’s third quarter fiscal 2025 conference call. … As Greg detailed, our third-quarter results were very strong, … devices, diagnostic equipment, and pharma solutions where our PII …
-
Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results
16 Jun 2025 22:40 GMT
FARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 2025. Financial Highlights
The Company’s third-quarter revenue of …
-
1933 Industries Reports Profit in Third Quarter 2025 Financial Results
16 Jun 2025 13:52 GMT
… is pleased to announce its third quarter financial results ("Q3 … during Q1 2025.
Gross Profit
Gross profit was $2.5 million … margin calculated as gross profit divided by revenue was … its wholly owned subsidiary, FN Pharmaceuticals, and Mr. Caleb Zobrist …
-
Crude Oil Rises Sharply; Jabil Earnings Top Views
17 Jun 2025 18:37 GMT
… expected third-quarter results on Tuesday.
The company reported quarterly adjusted earnings per … customers.
Equities Trading UP
Processa Pharmaceuticals, Inc. PCSA shares shot up … for gastroparesis.
Shares of Acurx Pharmaceuticals, Inc. ACXP got a …
-
Supernus Pharmaceuticals Set to Acquire Sage Therapeutics for $795 Million
16 Jun 2025 12:52 GMT
… and CAMBRIDGE, Mass. — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) has … be finalized in the third quarter of 2025, following … and CEO of Supernus Pharmaceuticals. “ZURZUVAE will help … 200 million, with significant earnings expected by 2026. Supernus …
-
Lilly to Acquire Verve Therapeutics in $1.3B Deal Targeting One-Time Gene-Editing Treatments for Cardiovascular Disease
17 Jun 2025 20:50 GMT
… acquisition of Verve signals strong pharma investment in one-time gene … expected to close in the third quarter of 2025, pending customary closing … in the company’s future earnings and guidance.
References
Eli Lilly …
-
Connecticut to get $64 million in $7.4 billion Purdue opioid settlement
17 Jun 2025 16:30 GMT
… and Connecticut-based Purdue Pharma and the Sackler family for … for Connecticut’s non-profit outpatient opioid treatment programs, … compared to 429 in the third quarter of 2021, according to … compared to 429 in the third quarter of 2021, according to …
-
Streamline Health® Reports Fiscal First Quarter 2025 Financial Results
16 Jun 2025 20:05 GMT
ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial …
-
What does 'REMAKE' AMERICA mean? (Honey, you shrunk the dollar)
15 Jun 2025 21:37 GMT
… of his supporters during the third quarter of 2009. Surprahse, surprahse … vilify the insurance industry, or drug-makers or even doctors. But my … a strawdog out of "profits" is as old as … 2007, General Motors earned a profit of $13.5 billion. …